glp-1/gcgr dual agonist Activation of GCGR and GLP-1R to promote insulin secretion in islet β Glp1/Gcgr dual agonist (DualAG) improved

And due to it has broad pharmaceutical know-how, along with a real international market footprint, Pfizer matters a lot in the healthcare space, especially where metabolic treatment is concerned

Tariverdian N, Siedentopf F, Rcke M, Blois SM, Klapp BF, Kentenich H, et al

Wegovy (semaglutide) EPAR product information [PDF online]

Absorption In patients with type 1 diabetes, after 8 days of once daily subcutaneous dosing with 0.4 units/kg of TRESIBA, maximum insulin degludec concentrations of 4472 pmol/L were attained at a median of 9 hours (tmax)

Why the Triple Agonist Approach The progression from single-receptor compounds through dual-receptor to triple-receptor approaches reflects a research-grounded principle: complementary receptor pathways can produce additive or synergistic effects in research that single-receptor compounds can't achieve

The decision should always be made together with a doctor and based on your individual situation